|
Title
|
|
|
|
¹⁸F-Florbetapir PET in primary cerebral amyloidoma
|
|
|
Author
|
|
|
|
|
|
|
Abstract
|
|
|
|
| Amyloid deposition can lead to Alzheimer disease and cerebral amyloid angiopathy. Rarely, it presents as a solitary focal deposition, primary cerebral amyloidoma, which can be misinterpreted as a neoplasm because of the "tumor-like" appearances. We present the case of a 54-year-old woman where MRI revealed a T2-hyperintense mass periventricular in the white matter with moderate contrast enhancement. Pathological investigation revealed AL (lambda) amyloidoma. F-18-florbetapir PET/CT was used to support the diagnosis and in follow-up. This case highlights that F-18-florbetapir PET/CT might play a role in the diagnostic workup of patients suggestive of cerebral amyloidoma, especially in cases where biopsy is not feasible. |
|
|
|
Language
|
|
|
|
English
|
|
|
Source (journal)
|
|
|
|
Clinical nuclear medicine. - Philadelphia, Pa
|
|
|
Publication
|
|
|
|
Philadelphia
:
Lippincott williams & wilkins
,
2020
|
|
|
ISSN
|
|
|
|
0363-9762
|
|
|
DOI
|
|
|
|
10.1097/RLU.0000000000003214
|
|
|
Volume/pages
|
|
|
|
45
:10
(2020)
, p. 838-839
|
|
|
ISI
|
|
|
|
000574567800044
|
|
|
Pubmed ID
|
|
|
|
32796236
|
|
|
Full text (Publisher's DOI)
|
|
|
|
|
|
|
Full text (publisher's version - intranet only)
|
|
|
|
|
|